 |
PDBsum entry 1fgb
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
251:550-562
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid.
|
|
R.G.Zhang,
M.L.Westbrook,
E.M.Westbrook,
D.L.Scott,
Z.Otwinowski,
P.R.Maulik,
R.A.Reed,
G.G.Shipley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cholera toxin, a heterohexameric AB5 enterotoxin released by Vibrio cholera,
induces a profuse secretory diarrhea in susceptible hosts. Choleragenoid, the B
subunit pentamer of cholera toxin, directs the enzymatic A subunit to its target
by binding the GM1 gangliosides exposed on the luminal surface of intestinal
epithelial cells. The crystal structure of choleragenoid has been independently
solved and refined at 2.4 A resolution by combining single isomorphous
replacement with non-crystallographic symmetry averaging. The structure of the B
subunits, and their pentameric arrangement, closely resembles that reported for
the intact holotoxin, choleragen, the heat-labile enterotoxin from Escherichia
coli, and for a choleragenoid-GM1 pentasaccharide complex. In the absence of the
A subunit the central cavity of the B pentamer is a highly solvated channel. The
binding of choleragenoid to the A subunit or to its receptor pentasaccharide
modestly affects the local stereochemistry without perceptibly altering the
subunit interface.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Overview of the crystalline choleragenoid. A, Stereo pair of the pentamer viewed from the ``side'' (along an
axis perpendicular to the 5-fold axis). Each subunit is colored differently with only the side-chains of Tyr12, Gln56, and
Trp88 shown (green). These residues surround the GM1-binding sites located adjacent to the ``ventral'' flange of
choleragenoid. The A subunit of the holotoxin lies on top of the ``dorsal'' surface. The disulfide bridges between residues
9 and 86 are colored magenta. The amino and carboxyl termini are shown as blue and red spheres, respectively. B, Stereo
pair of the pentamer viewed from the ``ventral'' surface (along an axis parallel to the 5-fold). Residues are indicated as
in A. The central pore of choleragen is occupied by the helical terminus of the A2 chain in the holotoxin (Zhang et al.,
1995).
|
 |
Figure 7.
Figure 7. The central pore of choleragenoid and choleragen. Cross-section through the central pore of (A) choleragenoid,
and (B) choleragen (Zhang et al., 1995) along the 5-fold axis. For clarity, only the side-chains of the central a-helices are
shown (magenta). Solvent molecules are indicates as yellow spheres. The carboxyl end of the A2 chain (gold) occupies
the central pore of choleragen. Part of the A1 chain (cyan) is also shown in B for orientation purposes. In the absence of
the A2 chain, the pore is a highly solvated channel. The location of the ganglioside-binding site is indicated by the
side-chain of Trp88 (green).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1995,
251,
550-562)
copyright 1995.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.B.Watkins,
C.E.Miller,
J.Majewski,
and
T.L.Kuhl
(2011).
Membrane texture induced by specific protein binding and receptor clustering: active roles for lipids in cellular function.
|
| |
Proc Natl Acad Sci U S A,
108,
6975-6980.
|
 |
|
|
|
|
 |
C.E.Miller,
J.Majewski,
E.B.Watkins,
M.Weygand,
and
T.L.Kuhl
(2008).
Part II: diffraction from two-dimensional cholera toxin crystals bound to their receptors in a lipid monolayer.
|
| |
Biophys J,
95,
641-647.
|
 |
|
|
|
|
 |
C.E.Miller,
J.Majewski,
E.B.Watkins,
and
T.L.Kuhl
(2008).
Part I: an x-ray scattering study of cholera toxin penetration and induced phase transformations in lipid membranes.
|
| |
Biophys J,
95,
629-640.
|
 |
|
|
|
|
 |
C.Reich,
M.R.Horton,
B.Krause,
A.P.Gast,
J.O.Rädler,
and
B.Nickel
(2008).
Asymmetric structural features in single supported lipid bilayers containing cholesterol and GM1 resolved with synchrotron X-Ray reflectivity.
|
| |
Biophys J,
95,
657-668.
|
 |
|
|
|
|
 |
S.Sakaguchi,
and
T.Arakawa
(2007).
Recent developments in mucosal vaccines against prion diseases.
|
| |
Expert Rev Vaccines,
6,
75-85.
|
 |
|
|
|
|
 |
D.Li,
J.O'Leary,
Y.Huang,
N.P.Huner,
A.M.Jevnikar,
and
S.Ma
(2006).
Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants.
|
| |
Plant Cell Rep,
25,
417-424.
|
 |
|
|
|
|
 |
J.P.Williams,
D.C.Smith,
B.N.Green,
B.D.Marsden,
K.R.Jennings,
L.M.Roberts,
and
J.H.Scrivens
(2006).
Gas phase characterization of the noncovalent quaternary structure of cholera toxin and the cholera toxin B subunit pentamer.
|
| |
Biophys J,
90,
3246-3254.
|
 |
|
|
|
|
 |
M.Kowarik,
N.M.Young,
S.Numao,
B.L.Schulz,
I.Hug,
N.Callewaert,
D.C.Mills,
D.C.Watson,
M.Hernandez,
J.F.Kelly,
M.Wacker,
and
M.Aebi
(2006).
Definition of the bacterial N-glycosylation site consensus sequence.
|
| |
EMBO J,
25,
1957-1966.
|
 |
|
|
|
|
 |
M.M.Ngundi,
C.R.Taitt,
and
F.S.Ligler
(2006).
Simultaneous determination of kinetic parameters for the binding of cholera toxin to immobilized sialic acid and monoclonal antibody using an array biosensor.
|
| |
Biosens Bioelectron,
22,
124-130.
|
 |
|
|
|
|
 |
M.M.Ngundi,
C.R.Taitt,
S.A.McMurry,
D.Kahne,
and
F.S.Ligler
(2006).
Detection of bacterial toxins with monosaccharide arrays.
|
| |
Biosens Bioelectron,
21,
1195-1201.
|
 |
|
|
|
|
 |
T.Harakuni,
H.Sugawa,
A.Komesu,
M.Tadano,
and
T.Arakawa
(2005).
Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
|
| |
Infect Immun,
73,
5654-5665.
|
 |
|
|
|
|
 |
C.E.Miller,
J.Majewski,
R.Faller,
S.Satija,
and
T.L.Kuhl
(2004).
Cholera toxin assault on lipid monolayers containing ganglioside GM1.
|
| |
Biophys J,
86,
3700-3708.
|
 |
|
|
|
|
 |
C.Lesieur,
M.J.Cliff,
R.Carter,
R.F.James,
A.R.Clarke,
and
T.R.Hirst
(2002).
A kinetic model of intermediate formation during assembly of cholera toxin B-subunit pentamers.
|
| |
J Biol Chem,
277,
16697-16704.
|
 |
|
|
|
|
 |
M.G.Jobling,
and
R.K.Holmes
(2002).
Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras.
|
| |
Infect Immun,
70,
1260-1271.
|
 |
|
|
|
|
 |
Y.Yuki,
Y.Byun,
M.Fujita,
W.Izutani,
T.Suzuki,
S.Udaka,
K.Fujihashi,
J.R.McGhee,
and
H.Kiyono
(2001).
Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis.
|
| |
Biotechnol Bioeng,
74,
62-69.
|
 |
|
|
|
|
 |
K.Saxena,
P.Zimmermann,
R.R.Schmidt,
and
G.G.Shipley
(2000).
Bilayer properties of totally synthetic C16:0-lactosyl-ceramide.
|
| |
Biophys J,
78,
306-312.
|
 |
|
|
|
|
 |
A.Zitzer,
O.Zitzer,
S.Bhakdi,
and
M.Palmer
(1999).
Oligomerization of Vibrio cholerae cytolysin yields a pentameric pore and has a dual specificity for cholesterol and sphingolipids in the target membrane.
|
| |
J Biol Chem,
274,
1375-1380.
|
 |
|
|
|
|
 |
D.Matković-Calogović,
A.Loregian,
M.R.D'Acunto,
R.Battistutta,
A.Tossi,
G.Palù,
and
G.Zanotti
(1999).
Crystal structure of the B subunit of Escherichia coli heat-labile enterotoxin carrying peptides with anti-herpes simplex virus type 1 activity.
|
| |
J Biol Chem,
274,
8764-8769.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.M.Kavic,
E.J.Frehm,
and
A.S.Segal
(1999).
Case studies in cholera: lessons in medical history and science.
|
| |
Yale J Biol Med,
72,
393-408.
|
 |
|
|
|
|
 |
W.I.Lencer,
T.R.Hirst,
and
R.K.Holmes
(1999).
Membrane traffic and the cellular uptake of cholera toxin.
|
| |
Biochim Biophys Acta,
1450,
177-190.
|
 |
|
|
|
|
 |
J.P.Raufman
(1998).
Cholera.
|
| |
Am J Med,
104,
386-394.
|
 |
|
|
|
|
 |
L.de Haan,
W.Verweij,
E.Agsteribbe,
and
J.Wilschut
(1998).
The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.
|
| |
Immunol Cell Biol,
76,
270-279.
|
 |
|
|
|
|
 |
E.A.Merritt,
S.Sarfaty,
I.K.Feil,
and
W.G.Hol
(1997).
Structural foundation for the design of receptor antagonists targeting Escherichia coli heat-labile enterotoxin.
|
| |
Structure,
5,
1485-1499.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.A.McCann,
J.A.Mertz,
J.Czworkowski,
and
W.D.Picking
(1997).
Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure.
|
| |
Biochemistry,
36,
9169-9178.
|
 |
|
|
|
|
 |
L.W.Ruddock,
H.M.Webb,
S.P.Ruston,
C.Cheesman,
R.B.Freedman,
and
T.R.Hirst
(1996).
A pH-dependent conformational change in the B-subunit pentamer of Escherichia coli heat-labile enterotoxin: structural basis and possible functional role for a conserved feature of the AB5 toxin family.
|
| |
Biochemistry,
35,
16069-16076.
|
 |
|
|
|
|
 |
L.W.Ruddock,
J.J.Coen,
C.Cheesman,
R.B.Freedman,
and
T.R.Hirst
(1996).
Assembly of the B subunit pentamer of Escherichia coli heat-labile enterotoxin. Kinetics and molecular basis of rate-limiting steps in vitro.
|
| |
J Biol Chem,
271,
19118-19123.
|
 |
|
|
|
|
 |
R.A.Reed,
and
G.G.Shipley
(1996).
Properties of ganglioside GM1 in phosphatidylcholine bilayer membranes.
|
| |
Biophys J,
70,
1363-1372.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |